United States: William B. Kezer Joins Mintz Levin’s IP Practice
Last Updated: March 8 2016

We are excited to announce the arrival of Bill Kezer, PhD, the newest Member in our Intellectual Property Practice.  Bill joins our team in San Francisco, where he deepens our bench in the chemical and pharmaceutical spaces.   He brings a unique perspective to client service, with experience as a research scientist and project leader at two major companies prior to law school, and then as in-house patent counsel before entering private practice.

Bill takes a business-based, product-driven approach to the strategic development of patent portfolios, due diligence reviews of targeted companies and technology, and comparative evaluations of competitive patented technologies. He also works with clients to procure global patent protection for pharmaceutical inventions, and focuses on product protection strategies involving formulations, drug delivery technologies, and dosing methods.

To read more about Bill's arrival, please click here.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Gilbert Samberg
By Samantha Kingsbury
By Matthew Howsare, Shawn N. Skolky
By Philip C Ducker, Stephen J. Akerley
By Christina Sperry, John Buchanan
By Kevin Mortimer, Peter Saparoff, Joel Rothman
By Brad Scheller, Linyu Mitra
By Gilbert Samberg
By Cynthia Larose
By Eli Greenspan, Katie Weider, Rodney Whitlock
Tools
Print
Font Size:
Translation
Channels